← All trials
NCT00898287
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 1, 2009
- Primary completion
- Dec 1, 2010
- Completion date
- —
- First posted
- —
- Last posted
- —
- Enrollment
- 23
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- PiramalLead sponsor
- Lifeline Mutispecilaity Hospital, Chennai, IndiaOverall official - principal investigator
- Global Hospital, HyderabadOverall official - principal investigator
- Deenanath Mangeshkar Hospital & Research CentreOverall official - principal investigator
- Curie Manavata Cancer Center, Nashik, IndiaOverall official - principal investigator
- Sri Ramachandra Medical College, ChennaiOverall official - principal investigator
- Meenakshi Ammal Dental College and HospitalOverall official - principal investigator
- Central India Cancer Research Institute, NagpurOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.